PHSA Laboratories CW Site - Point of Care
Title: CWPC_GLU_0140 Accu-Chek Inform II Training Guide
Medical Approval: Dr Benjamin Jung
Medical Approval Date: 27 Dec 2016
Version: 1.2
Implementation Date: 7/2/2019 11:55:59 PM
Folder Name: CW\Point of Care\Whole Blood Glucose
This is a controlled document for CW use only. Any printed copies are uncontrolled unless specified. Please refer to Lab QMS
Page
11
of
12
AccuChek Inform II Test Strip Limitations:
Galactose
Elevated Galactose can occur in neonates with inherited galactosemia (1 per
40,000 in BC).
First glucose value for neonates > 5.5 mmol/L is checked
simultaneously with a lab glucose during first 5 days of life.
(Collect a lab draw prior to next scheduled feed).
Clinical assessment of patient important to identify neonatal galactosemia.
Use a Lab Draw to confirm any unexpected high neonate glucose result. Consult
with physician.
During the treatment of parenterally galactose containing drugs:
(eg. Echovist and Levovist) Send to lab, or repeat the test after the half-life of
drug.
Triglycerides – interference if > 20 mmol/L
far beyond average values
Concentrations above 5.7 mmol/L are considered very high.
An extremely low number of people have concentrations of 20 mmol/L or higher.
Ascorbic Acid – interference if > 0.17 mmol/L
ICU patients receiving high dose IV ascorbic acid as support
Questions & Inform II Competency Checklist
When the Competency Checklist is completed by the operators, please collect.
Return to Point of Care Testing Office at the end of the day for record keeping.
Note: @ PHSA there is a Presentation with a Quiz to view on the Learning Hub. Part of
the certification process.
